Choline Source
Alpha-GPC
A readily absorbed choline source that helps the brain make acetylcholine — a chemical tied to memory and focus.
KÖGN Health grades Alpha-GPC as A+ (Strong evidence) and rates it 4.4 out of 5.
Last reviewed · June 2026
Primary effects
- Improved memory
- Enhanced learning
- Increased focus
- Cognitive clarity
How it works
Increases acetylcholine levels, enhancing memory formation, learning, and cognitive processing.
Overview
Alpha-GPC is one of the most effective choline sources due to its ability to efficiently cross the blood-brain barrier and directly support acetylcholine synthesis. It is widely used in both cognitive enhancement and physical performance contexts, particularly for its role in neuromuscular signalling. It is often paired with racetams to prevent choline depletion and optimise effects. Benefits can be felt relatively quickly, but it also supports long-term cognitive function with regular use.
The evidence
Most controlled evidence comes from clinical populations: trials in mild-to-moderate Alzheimer's and vascular cognitive impairment (e.g. 1,200 mg/day) have shown benefit on cognitive scales, and a 2024 randomised trial reported gains in amnestic mild cognitive impairment. Robust trials in healthy adults are sparse, so its popularity for everyday focus runs ahead of the direct evidence.
How to dose it
Studied at 300–600 mg per day for general cognitive use, and up to 1,200 mg/day (often split) in dementia trials. Taken with or without food.
When to take it
Both. Some use it acutely before demanding work for its cholinergic 'lift'; the clinical evidence comes from sustained daily use.
Safety & side effects
Generally well tolerated; the most common effects are headache, heartburn, and trouble sleeping if taken late. Cholinergic load can cause a heavy-headed feeling in sensitive people.
Who should avoid it
Some observational data have linked high long-term alpha-GPC intake to raised stroke risk; the finding is not settled but warrants caution if you have cardiovascular or cerebrovascular risk factors — discuss with a clinician. Safety in pregnancy is not established.
References
Related ingredients
Graded entries that target the same cognitive goals.
Categories
Draft — the dose, safety and evidence notes on this entry were prepared from the published literature and are pending editorial and clinical review.
Educational information, not medical advice. The evidence grade is KÖGN’s editorial assessment of published research, not a health claim. Speak to a qualified clinician before changing what you take.